Effects of methamphetamine on actigraphy-based sleep parameters in female rhesus monkeys: Orexin receptor mechanisms
Authors:
- Daniel A. BorgattiDBDaniel A. Borgatti
- James K. RowlettJRJames K. Rowlett
- Lais F. BerroLBLais F. Berro
- 5 April 2024
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 259
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse (DA046778, DA043204, DA011792, DA049886)
This publication has 39 references indexed in Scilit:
- Orexin Receptor Antagonists and InsomniaCurrent Psychiatry Reports, 2022
- Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in AddictionBiological Psychiatry, 2022
- Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US AdultsJAMA Psychiatry, 2021
- Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use DisorderJAMA Psychiatry, 2020
- The contribution of orexins to sex differences in the stress responseBrain Research, 2020
- Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in RatsBiological Psychiatry, 2019
- Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeysPsychopharmacology, 2017
- Orexin OX2 Receptor Antagonists as Sleep Aids2016
- Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of InsomniaChemMedChem, 2013
- Residual effects of intranasal methamphetamine on sleep, mood, and performanceDrug and Alcohol Dependence, 2008